Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
The companies say the vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
Merck, Moderna melanoma vaccine succeeds
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial IOL —
- Merck, Moderna Melanoma Vaccine Study Succeeds Bloomberg —
- Merck, Moderna claim encouraging melanoma vaccine trial results South China Morning Post —
- Merck, Moderna Stocks Soar After Melanoma Trial Success 📹 Bloomberg — · 2min
- Moderna Cancer Trial Success Is a Shot in the Arm for Trump Newsweek —